# Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yeming Wang,Dingyu Zhang,Guanhua Du,Ronghui Du,Jianping Zhao,Yang Jin,Shouzhi Fu,Ling Gao,Zhenshun Cheng,Qiaofa Lu,Yi Hu,Guangwei Luo,Ke Wang,Yang Lü,Huadong Li,Shuzhen Wang,Shunan Ruan,Haijun Yang,Chunlin Mei,Yi Wang,Dan Ding,Feng Wu,Xin Tang,Xianzhi Ye,Yingchun Ye,Bing Liu,Jie Yang,Wen Yin,Aili Wang,Guohui Fan,Fei Zhou,Zhibo Liu,Xiaoying Gu,Jiuyang Xu,Lianhan Shang,Yi Zhang,Lianjun Cao,Tingting Guo,Yan Wan,Hong Qin,Yushen Jiang,Thomas Jaki,Frederick G. Hayden,Peter Horby,Bin Cao,Chen Wang |
| Citations | 3,664 |
| DOI | 10.1016/s0140-6736(20)31022-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S0140673620310229/pdf |
| OpenAlex ID | https://openalex.org/W3018023298 |
| PMID | 32423584 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yi Zhang](https://scholariq.org/researchers/yi-zhang/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Pharmacological Receptor Mechanisms and Effects](https://scholariq.org/topics/pharmacological-receptor-mechanisms-and-effects/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.